trial · primary record
EIK1005
Advanced Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 160 |
| Primary completion | 2029-03 |
| Primary endpoint | Dose-Limiting Toxicity (DLT) - Part 1 |
| Registry ID | NCT07262619 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:51.526Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07262619
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.